| NCT ID | NCT05541029 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Pittsburgh |
| Condition | Critical Illness |
| Study Type | INTERVENTIONAL |
| Enrollment | 171 participants |
| Start Date | 2023-03-20 |
| Primary Completion | 2027-04-08 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 171 participants in total. It began in 2023-03-20 with a primary completion date of 2027-04-08.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
A randomized within-subject crossover trial to compare the effects of live and recorded music listening on biomarkers of stress and pain among children receiving mechanical ventilation in the pediatric intensive care unit.
Eligibility Criteria
Inclusion Criteria: * 2 months -17 years old * intubated and receiving MV * expected to have a PICU stay of \>72 hours Exclusion Criteria: * Primary caregiver does not read, write, and speak English * The child is not expected to survive the PICU stay * The child has deafness in both ears, has a history of musicogenic epilepsy, is receiving neuromuscular blockade infusion * The child has a diagnosis of COVID-19 * The child was admitted for a new traumatic brain injury
Contact & Investigator
Jessica M Jarvis, PhD
PRINCIPAL INVESTIGATOR
University of Pittsburgh
Frequently Asked Questions
Who can join the NCT05541029 clinical trial?
This trial is open to participants of all sexes, aged 2 Months or older, up to 17 Years, studying Critical Illness. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05541029 currently recruiting?
Yes, NCT05541029 is actively recruiting participants. Contact the research team at eldridgejl@upmc.edu for enrollment information.
Where is the NCT05541029 trial being conducted?
This trial is being conducted at Pittsburgh, United States.
Who is sponsoring the NCT05541029 clinical trial?
NCT05541029 is sponsored by University of Pittsburgh. The principal investigator is Jessica M Jarvis, PhD at University of Pittsburgh. The trial plans to enroll 171 participants.